SUCRAID SIDE EFFECTS
- Generic Name: sacrosidase oral solution
- Brand Name: Sucraid
- Drug Class: Enzymes, Metabolic
Adverse experiences with Sucraid in clinical trials were generally minor and were frequently associated with the underlying disease.
In clinical studies of up to 54 months duration, physicians treated a total of 52 patients with Sucraid. The adverse experiences and respective number of patients reporting each event (in parenthesis) were as follows: abdominal pain (4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1), headache (1), nervousness (1), and dehydration (1).
Note: diarrhea and abdominal pain can be a part of the clinical presentation of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID).
One asthmatic child experienced a serious hypersensitivity reaction (wheezing) probably related to sacrosidase. The event resulted in withdrawal of the patient from the trial but resolved with no sequelae.
SRC: NLM .